Logo

Ann Rhoads

Jan 04, 2018

Counsyl has appointed Ann Rhoads to its board of directors. Rhoads is former executive vice president and CFO at pharmaceutical company Zogenix. Previously, she was CFO and senior vice president at Premier. She currently serves as a board member and chair of the audit committee at Globus Medical, a musculoskeletal company, and Evoke Pharma, a pharmaceutical company that focuses on gastrointestinal disease. Rhoads Is also a board member and chair of the compensation committee at ophthalmic laser company Iridex Corporation. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.